Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Radiation Oncology
•
Palliation
•
Neuro-Oncology
•
Medical Oncology
•
CNS Disease
•
Drug Toxicity
Is it safe to give large fraction stereotactic irradiation for brain metastases concurrently with VEGF inhibitors?
Related Questions
How well does a negative non-contrast MRI of the brain exclude metastasis in a patient with squamous cell carcinoma of the lung?
What are the best radiation therapy options for a young adult with 3 brain metastases from myeloid sarcoma that hasn’t responded well to intrathecal therapy?
Would patients receiving targeted therapies be eligible for TTFields for brain metastases?
Under what circumstances would you consider irradiation for brain metastases with active or recent bleeding?
How will you select patients with brain metastases for TTFields?
What is the optimal management of pain and loss of function due to pathologic compression fractures?
Do you utilize tumor treating fields in patients with anaplastic pleomorphic xanthoastrocytoma (PXA) III?
In what circumstances would you consider use of IDH inhibitors in high-grade astrocytomas?
How would you manage an enlarging brain metastasis that has progressed in size three months after radiosurgery?
Would you offer a third course of palliative radiation after two courses of 8 Gy in 1 fx?
